Nova Biologiques is a private Canadian R&D company dedicated to develop and produce new products based on the expression of recombinant proteins. As a technically-driven business, we are conducting our research through a combination of external collaborations and internal projects. Our key ongoing collaborations include research centers in Asia, more specifically in China. The internal projects are conducted at our specialized laboratory in Montreal. The mission of Nova Biologiques is to perform research that facilitates the development of effective vaccines for viral diseases. We are carrying on programs of research and work with scientists in academic and industrial laboratories through national and international collaborations. Our scientific advances, methodologies, and resources are providing the basis for research on vaccines and recombinant proteins. In 2008 and early 2009, Nova Biologiques successfully evaluated the safety and immunogenicity of a recombinant vaccine. The administrative offices of Nova Biologiques are located in Montreal, Quebec, Canada.
View Top Employees from Nova BiologiquesWebsite | http://novabiologiques.com |
Revenue | $1 million |
Employees | View employees |
Address | 1975 Hymus Blvd, Dorval, Quebec H9P 1J8, CA |
Phone | (514) 684-9490 |
Industry | Chemicals, Petrochemicals, Glass & Gases, Manufacturing |
SIC | SIC Code 28 Companies, SIC Code 283 Companies |
NAICS | NAICS Code 32 Companies, NAICS Code 325414 Companies, NAICS Code 325 Companies, NAICS Code 3254 Companies, NAICS Code 32541 Companies |
Looking for a particular Nova Biologiques employee's phone or email?
The Nova Biologiques annual revenue was $1 million in 2024.
Nova Biologiques is based in Dorval, Quebec.
The NAICS codes for Nova Biologiques are [32, 325414, 325, 3254, 32541].
The SIC codes for Nova Biologiques are [28, 283].